SCHEMBL7963791

SCHEMBL7963791

CCOC(Cc1ccc(OCCC=C2c3sccc3-c3ccsc32)cc1)C(=O)O

nearest known ligand 0.68

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARG P37231 14/20 0.68
PPARA Q07869 16/20 0.61
PPARD Q03181 8/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7966124 0.91 PPARG (0.56) PPARGPPARAPPARD
SCHEMBL7954590 0.90 PPARG (0.54) PPARGPPARAPPARD
SCHEMBL7965707 0.90 PPARA (0.70) PPARGPPARAPPARD
SCHEMBL7965896 0.85 PPARG (0.49) PPARGPPARAPPARD
SCHEMBL6731789 0.83 PPARG (0.83) PPARGPPARAPPARD
SCHEMBL6738433 0.81 PPARG (1.00) PPARGPPARAPPARD
SCHEMBL7965982 0.80 PPARA (0.57) PPARGPPARAPPARD
SCHEMBL7969533 0.80 PPARG (0.70) PPARGPPARAPPARD
SCHEMBL7968916 0.80 PPARG (0.65) PPARGPPARAPPARD
SCHEMBL6731219 0.79 PPARA (0.80) PPARGPPARAPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6300339-B1 USEFUL FOR THRERAPY AND/OR PROPHYLAXIS OF INSULIN RESISTANCE (TYPE 2 DIABETES), IMPAIRED GLUCOSE TOLERANCE, DYSLIPIDEMIA, HYPERTENSION, OBESITY, INSULIN RESISTANCE, HYPERGLYCEMIA, ATHEROSCLEROSIS, HYPERLIPIDEMIA, CORONARY ARTERY DISEASE NOVO NORDISK A/S (DK) 2001-10-09 US claimed